You are here:

  1. Home
  2. NICE Guidance
  3. Published Guidance

Dupilumab for treating moderate to severe prurigo nodularis

  • Technology appraisal guidance
  • Reference number: TA955
  • Published:  13 March 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top